Looking for Pentetic Acid Excipient pharmaceutical excipients? Find information on Pentetic Acid Excipient's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDF DOSSIERS SUPPLIERS

read-more
read-more

01

arrow
Aus. Peptide Conference
Not Confirmed
Germany
arrow
Aus. Peptide Conference
Not Confirmed

GADOPENTETATE DIMEGLUMINE

Drug : MAGNEVIST

Dosage Form : INJECTABLE; INJECTION

Application Number : 19596

Country : US

Patented : No

blank

02

arrow
Aus. Peptide Conference
Not Confirmed
Germany
arrow
Aus. Peptide Conference
Not Confirmed

GADOPENTETATE DIMEGLUMINE

Drug : MAGNEVIST

Dosage Form : INJECTABLE; INJECTION

Application Number : 21037

Country : US

Patented : No

blank

03

arrow
Aus. Peptide Conference
Not Confirmed
Italy
arrow
Aus. Peptide Conference
Not Confirmed

SINCALIDE

Drug : KINEVAC

Dosage Form : POWDER; INTRAVENOUS

Application Number : 17697

Country : US

Patented : No

blank

04

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

NIVOLUMAB; RELATLIMAB-RMBW

Drug : OPDUALAG

Dosage Form : SOLUTION; INTRAVENOUS

Application Number : 761234

Country : US

Patented : No

blank

05

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

SINCALIDE

Drug : SINCALIDE

Dosage Form : POWDER; INTRAVENOUS

Application Number : 210850

Country : US

Patented : Yes

blank

06

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

IBRITUMOMAB TIUXETAN

Drug : ZEVALIN

Dosage Form : INJECTABLE; INJECTION

Application Number : 125019

Country : US

Patented : No

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty